Showing 1081-1090 of 5771 results for "".
The Disruptees Can Become the Disruptors
https://modernod.com/topics/business/the-disruptees-can-become-the-disruptors/38201/Some things we have seen as threats may actually offer opportunities.Potential Silver Linings in the Gray COVID Cloud
https://modernod.com/topics/contact-lenses/potential-silver-linings-in-the-gray-covid-cloud/38169/Take this time to better yourself, your practice, and your patients’ experience.Cancer Treatment and the Eyes
https://modernod.com/topics/technology/cancer-treatment-and-the-eyes/38147/Some lifesaving therapies can have vision-threatening side-effects.Artificial Intelligence for Topography-Guided Procedures
https://modernod.com/mod-issues/2020-sept/artificial-intelligence-for-topography-guided-procedures/39108/Phorcides technology crunches big numbers, fast.Optometry School and COVID-19
https://modernod.com/topics/technology/optometry-school-and-covid-19/38123/A fourth-year optometry student’s perspective.Myopia Control: What It Is and How to Talk to Your Patients About It
https://modernod.com/topics/myopia/myopia-control-what-it-is-and-how-to-talk-to-your-patients-about-it/38122/A breakdown of myopia control to help better your practice and your care.Practicing Optometry During the COVID-19 Pandemic
https://modernod.com/topics/business/practicing-optometry-during-the-covid-19-pandemic/38096/A look at how much one practice changed in 30 days.Ushering in a New Treatment Paradigm for Glaucoma: Updates on Novel Therapeutics and Disease-Modifying Treatments
https://modernod.com/topics/glaucoma/ushering-in-a-new-treatment-paradigm-for-glaucoma-updates-on-novel-therapeutics-and-disease-modifying-treatments/38079/The Virtues of Emergency Eye Care
https://modernod.com/topics/business/the-virtues-of-emergency-eye-care/38067/You’ll be warmly rewarded for providing this much-needed service.CXL: What It Is, and When to Refer
https://modernod.com/mod-issues/2020-mar/cxl-what-it-is-and-when-to-refer/39098/A US clinical trial of epi-on corneal collagen crosslinking is expected to be completed this year.